BMJ 2007;334:1198-1200 (9 June), doi:10.1136/bmj.39226.400694.80
Analysis
Formula estimation of glomerular filtration rate: have we gone wrong?
Paul D Giles, consultant chemical pathologist1,
David A Fitzmaurice, professor2
1 Department of Biochemistry, Manor Hospital, Walsall WS2 9PS ,
2 Department of Primary Care and General Practice, University of Birmingham, Birmingham B15 2TT
Correspondence to: P D Giles paul.giles@walsallhospitals.nhs.uk
Paul D Giles and David A Fitzmaurice argue that the introduction of estimated glomerular filtration rate to screen for chronic kidney disease in primary care will lead to pressure on specialist services and create patient anxiety without clear proof of benefit
| The first 150 words of the full text of this article appear below. |
Chronic kidney disease is a public health problem worldwide.1 The estimated prevalence of established renal failure is around 1400 per million in the United States and more than 600 per million in the United Kingdom. Patients with chronic kidney disease have increased risk of cardiovascular disease. A test that reliably detects early kidney disease could help minimise cardiovascular disease and renal failure.
Estimating glomerular filtration rate
The best known function of the kidneys is plasma filtrationmeasured by the glomerular filtration rate (GFR). Many of the kidney's functions are related to GFR (box 1). Inulin clearance and modern isotopic methods are not practical for measuring GFR in routine practice. Creatinine based tests are used instead but have several disadvantages. Creatinine clearance involves timed urine collection and is prone to error. Measuring serum creatinine is easier but this test cannot detect early kidney disease.2 Routine reporting of estimated GFR using formulas based on serum creatinine concentration . . . [Full text of this article]
Box 1 Functions of the kidneys related to glomerular filtration rate3
Box 2 Estimating glomerular filtration rate (GFR) using the four variable version of the modification of diet in renal disease equation
Clinical indications for assessing glomerular function
Detecting changes in renal function over timeDisease staging in patients with chronic kidney disease Detecting chronic kidney disease in mixed populationsAnalytical considerations
Conclusion
Summary points

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Articles
-
Time to move forward
- C R V Tomson, E J Lamb, K Griffith, D O'Donoghue, and J Feehally
BMJ 2007 335: 111.
[Extract]
[Full Text]
[PDF]
-
Reporting eGFR has benefits
- Charlotte E Bebb and Richard P Burden
BMJ 2007 334: 1287.
[Extract]
[Full Text]
[PDF]
-
eGFR in changing drug regimens
- Jeffrey K Aronson
BMJ 2007 334: 1287.
[Extract]
[Full Text]
[PDF]
-
Chronic kidney disease
- Prabir Kumar Mitra, Peter R W Tasker, and M S Ell
BMJ 2007 334: 1273.
[Extract]
[Full Text]
[PDF]
-
How to measure renal function in clinical practice
- Jamie Traynor, Robert Mactier, Colin C Geddes, and Jonathan G Fox
BMJ 2006 333: 733-737.
[Extract]
[Full Text]
[PDF]
This article has been cited by other articles:
-
Innes, A.
(2008). The detection of advanced chronic kidney disease by surveillance of elevated plasma creatinines--a five-year experience. Nephrol Dial Transplant
0: gfn069v1-gfn069
[Abstract]
[Full text]
-
Richards, N., Harris, K., Whitfield, M., O'Donoghue, D., Lewis, R., Mansell, M., Thomas, S., Townend, J., Eames, M., Marcelli, D.
(2008). Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes. Nephrol Dial Transplant
23: 549-555
[Abstract]
[Full text]
-
Tomson, C R V, Lamb, E J, Griffith, K, O'Donoghue, D, Feehally, J
(2007). Time to move forward. BMJ
335: 111-111
[Full text]
-
Bebb, C. E, Burden, R. P
(2007). Reporting eGFR has benefits. BMJ
334: 1287-1287
[Full text]
-
Aronson, J. K
(2007). eGFR in changing drug regimens. BMJ
334: 1287-1287
[Full text]
Rapid Responses:
Read all Rapid Responses
- Estimating glomerular filtration rate in changing drug dosage regimens
- Jeffrey K Aronson
bmj.com, 10 Jun 2007
[Full text]
- Benefits of eGFR reporting
- Charlotte E Bebb, et al.
bmj.com, 12 Jun 2007
[Full text]
- How wrong can we go?
- Jo Richardson
bmj.com, 13 Jun 2007
[Full text]
- How eGFR has improved patient management
- Shelagh E O'Riordan, et al.
bmj.com, 5 Jul 2007
[Full text]
- Perhaps just with the formula
- Michael A Innes
bmj.com, 18 Jun 2007
[Full text]
- Estimating GFR – time to move forwards
- Edmund J Lamb, et al.
bmj.com, 19 Jun 2007
[Full text]
- Protagonists must demonstrate the value of eGFR
- James A Dickinson
bmj.com, 20 Jun 2007
[Full text]
- Estimated GFR in primary care: the value of awareness!
- Liam G Glynn, et al.
bmj.com, 25 Jun 2007
[Full text]
- Creatinine-based equations and the true cost of convenience
- Charles J. Diskin
bmj.com, 5 Jul 2007
[Full text]